FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

2378811000001100: Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-May 2006. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
25045701000001117 Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule (product) en Fully specified name Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module
38047201000001113 Magnapen 250mg/250mg capsules (Wockhardt UK Ltd) 20 capsule en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Is a Co-fluampicil 250mg/250mg capsules 20 capsule true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Is pack of Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has active ingredient Ampicillin trihydrate false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has active ingredient Ampicillin false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has active ingredient Flucloxacillin false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has active ingredient Flucloxacillin sodium false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has active ingredient Flucloxacillin sodium false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has manufactured dose form Oral dose form false Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has AMP Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has specific active ingredient Ampicillin trihydrate true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has specific active ingredient Flucloxacillin sodium true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has dispensed dose form Capsule true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has basis of strength substance Ampicillin true Inferred relationship Existential restriction modifier
Magnapen 250mg/250mg capsules (C P Pharmaceuticals Ltd) 20 capsule Has basis of strength substance Flucloxacillin true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start